- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Novel COVID-19-Infected Pneumonia in India
Total 118 results
-
Pharm-Olam, LLCBiomedical Advanced Research and Development AuthorityTerminatedCOVID-19United States, South Africa, Colombia, Guadeloupe, India, Mexico, Puerto Rico
-
Novartis PharmaceuticalsMolecular Partners AGTerminatedCOVID-19United States, India, Hungary, Netherlands, South Africa
-
University of BolognaCharite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaboratorsRecruitingSARS CoV 2 Infection | Vaccination; Infection | Breakthrough InfectionArgentina, Gabon, India, Ireland, Italy, Luxembourg, Netherlands, Spain
-
Vicore Pharma ABCompletedCOVID-19Philippines, United States, Brazil, India, Russian Federation, Colombia, Argentina, Czechia, South Africa, Ukraine
-
Sanofi Pasteur, a Sanofi CompanyActive, not recruitingCOVID-19United States, Colombia, Ghana, Honduras, India, Japan, Kenya, Mexico, Nepal, Nigeria, Sri Lanka, Uganda, Ukraine
-
Dr. Reddy's Laboratories LimitedGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry... and other collaboratorsActive, not recruiting
-
Eli Lilly and CompanyCompletedCOVID-19United States, Spain, India, Germany, Puerto Rico, Brazil, Korea, Republic of, Argentina, Italy, Japan, Mexico, Russian Federation, United Kingdom
-
Bharat Biotech International LimitedCompletedCOVID-19 Respiratory InfectionIndia
-
PfizerCompletedCOVID-19United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
-
Saint Luke's Health SystemAstraZeneca; George Clinical Pty Ltd; Saint Luke's Hospital of Kansas CityCompletedCOVID-19United States, Brazil, Argentina, India, Canada, Mexico, United Kingdom
-
Population Health Research InstituteBayerCompletedSevere Acute Respiratory Syndrome | CoronavirusEgypt, Canada, Brazil, Colombia, Ecuador, India, Nepal, Pakistan, Philippines, Russian Federation, South Africa, United Arab Emirates
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
University of California, San DiegoEnrolling by invitationCovid19 | AKI | ESRD | CKD | Transplant;Failure,KidneyUnited States, United Kingdom, Chile, Canada, India, Bolivia
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)Active, not recruitingA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
Bharat Biotech International LimitedActive, not recruitingCOVID-19 Respiratory InfectionIndia
-
Synairgen Research Ltd.CompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
-
Kirby InstituteViiV Healthcare; University of Witwatersrand, South Africa; University of Liverpool and other collaboratorsCompletedCoronavirus Infection | HIV-infection/AidsUganda, Cameroon, Argentina, Brazil, India, Malaysia, Nigeria, South Africa, Thailand, Zimbabwe